Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marwa R. Al-Badri"'
Autor:
Shaheen Tomah, Ahmed H. Eldib, Mhd Wael Tasabehji, Joanna Mitri, Veronica Salsberg, Marwa R. Al-Badri, Hannah Gardner, Osama Hamdy
Publikováno v:
Nutrients, Vol 12, Iss 6, p 1643 (2020)
Dairy products are integral parts of healthy diets; however, their association with cardiometabolic (CM) health among patients with type 2 diabetes (T2D) undergoing weight management is debated. We examined the relationship between dairy consumption
Externí odkaz:
https://doaj.org/article/1a30335f15b84fd9856be3a845fe6421
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 6 (2015)
Gestational diabetes mellitus (GDM) is a complication of pregnancy that is characterized by impaired glucose tolerance with onset or first recognition during pregnancy. The reported prevalence of GDM varies between 0.6% and 20% of pregnancies dependi
Externí odkaz:
https://doaj.org/article/4937f2bb2e0b4ed7b8784979c15bb07a
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 5 (2014)
Hydroxychloroquine (HCQ), a commonly used antimalarial drug in rheumatic diseases, has shown favorable metabolic effects on both glucose control and lipid profiles. We describe a case of a young woman with type 1 diabetes whose glycemic control was o
Externí odkaz:
https://doaj.org/article/1e678f7509334526a1c43e675345daf8
Autor:
Marwa R. Al-Badri, Sami T. Azar
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 5 (2014)
Glucagon-like peptide-1 (GLP-1) agonists are a class of drugs used for the treatment of type 2 diabetes mellitus. GLP-1 is released in response to meal intake; these classes of drugs enhance glucose-dependent insulin secretion and exhibit other antih
Externí odkaz:
https://doaj.org/article/305bd73ba5b9480986a75d3743d464cc
Autor:
Osama Hamdy, Shaheen Tomah, Attia H. Hassan, Ahmed H. Eldib, Megahed M. Abuelmagd, Naim Alkhouri, Marwa R. Al-Badri, Hannah Gardner, Elsayed A. Eid
Publikováno v:
BMJ Open Gastroenterology, Vol 8, Iss 1 (2021)
BMJ Open Gastroenterology
BMJ Open Gastroenterology
ObjectiveLimited literature has examined the epidemiology of non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt, a country with one of the highest obesity rates globally. We assessed the prevalence of steatosis and fib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d94b7f33b8e804c31adc7219397273
https://bmjopengastro.bmj.com/content/8/1/e000780.full
https://bmjopengastro.bmj.com/content/8/1/e000780.full
Autor:
Aleksandar Kostic, Ahmed H. Eldib, Jeremy E. Wilkinson, Chengchen Li, Osama Hamdy, Mhd Wael Tasabehji, Hannah Gardner, Joanna Mitri, Shaheen Tomah, Marwa R. Al-Badri
Publikováno v:
Diabetes. 70
Studies have demonstrated differences in gut microbial characteristics in diseases compared to healthy states. Knowledge of how diet alters the gut microbiome is limited by the lack of dietary interventional studies reporting on gut microbial charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::806a6f5ca0efae4618405bb5b42b6a7b
https://doi.org/10.2337/db21-1183-p
https://doi.org/10.2337/db21-1183-p
Autor:
Jennie L. Votta, Jacqueline Shahar, Chandra L. Davis, Joan M. Beaton, Marwa R. Al-Badri, Cara L. Kilroy, Aaron M. Price, Jo-Anne M. Rizzotto, Hannah Gardner, Osama Hamdy, Shaheen Tomah, Aliza Phillips-Stoll, Mallory Sin
Publikováno v:
Diabetes. 70
Intensive lifestyle intervention (ILI) is essential for diabetes management. The Weight Achievement and Intensive Treatment (Why WAIT) program is a 12-week multidisciplinary weight management program that has been implemented in real-world clinical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56e4ec2d42599afaed7e7270d68ec208
https://doi.org/10.2337/db21-252-or
https://doi.org/10.2337/db21-252-or
Publikováno v:
Diabetes. 70
We previously reported that, in patients with diabetes, intensive lifestyle intervention (ILI) in real-world clinical practice could lead to significant weight loss that was attainable for up to 10 yrs and had favorable impact on glycemic control and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef25b978e7819583296c503c446a7020
https://doi.org/10.2337/db21-407-p
https://doi.org/10.2337/db21-407-p
Autor:
Ahmed H. Eldib, Astrid Atakov-Castillo, Elena Toschi, Mhd Wael Tasabehji, Osama Hamdy, Shilton Edward Dhaver, Shaheen Tomah, Marwa R. Al-Badri, Hannah Gardner
Publikováno v:
Diabetes. 69
The MiniMed™ 670G (670G) is the first FDA approved hybrid closed-loop insulin delivery system for patients with type 1 diabetes (T1D). In Auto Mode, the integrated continuous glucose monitor (CGM) captures glucose values every five minutes and, via
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dcb217acb981e286aa92a1a9e146ddf
https://doi.org/10.2337/db20-976-p
https://doi.org/10.2337/db20-976-p
Autor:
Osama Hamdy, Marwa R. Al-Badri
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Diabetes is a chronic disease that affects nearly 463 million people globally and involves multiple co-morbid conditions that require effective treatment and continuous management. These include lifestyle and behavioral modifications, compliance to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab808059db256caf128bd53eb604844
https://doi.org/10.1177/2042018821995368
https://doi.org/10.1177/2042018821995368